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Spasmodic dysphonia (SD) is rare focal dystonia affecting the laryngeal musculature. 
Patients with SD typically experience a strained or choked speech and report that it 
takes an exhausting effort for them to speak. The disorder develops spontaneously 
during midlife. Its progression is gradual in the first year and then becomes chronic for 
life. At present, there is no cure for SD and it is unresponsive to behavioral speech 
therapy. It is treated primarily with Botulinum toxin (Botox) injections for temporary 
symptom relief. Proprioceptive deficits are an underlying feature of SD - a finding that 
opens an avenue for a missing behavioral treatment for the disease. Specifically, vibro-
tactile stimulation (VTS) could be the suitable tool, given that it alters afferent signals 
from the mechanoreceptors in the vibrated muscles and skin. 
This cumulative dissertation concerns a non-invasive neuromodulation approach using 
VTS for treating the voice symptoms in people with SD. It consists of three separate 
projects. The first project examined the short-term effect of vibro-tactile stimulation (VTS) 
on speech quality and cortical activity of 12 participants with adductor SD and one with 
abductor SD. The results showed that 9 participants (69%) exhibited a reduction of voice 
breaks and/or a meaningful increase in smoothed cepstral peak prominence, an acoustic 
measure of voice/speech quality. Symptom improvements persisted for 20 minutes past 
VTS. In addition, VTS induced a significant suppression of theta band power over the left 
somatosensory-motor cortex and a significant rise of gamma rhythm over the right 
somatosensory-motor cortex. Our results show convincingly that VTS represents a non-
invasive form of neuromodulation that induces measurable short-term improvements in 
patients' speech with adductor SD. 
The second project represents a logical step to expand on the previous work to improve 
VTS technology and make it wearable. To that effect, I have designed and developed a 
wearable non-invasive collar-like device that applies VTS to the laryngeal muscles. The 
device provides two operational modes, continuous VTS and real-time VTS, using a 
developed speech detection technology. The speech detection algorithm allows for 
individualized system calibration providing flexibility in adjusting the device for users with 
different anatomy and/or disease severity. 
For the final project, I used the device that was developed in project 2 to examine the 
efficacy of VTS for treating voice symptoms in people with abductor SD. The results 
showed an improvement in at least one marker of voice quality for 3 out of 4 participants. 
The improvement lasted for 20 and 60 minutes after cessation of VTS for one 
participant. However, we require a larger sample to have a confident response rate to 
the laryngeal VTS in AB SD. The current analysis of electrocortical responses to VTS in 
people with AB SD did not closely mimic the event -elated cortical activity patterns seen 
in AD SD. More data are needed to delineate consistent patterns of cortical responses 
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This dissertation concerns a non-invasive neuromodulation approach for treating the 
voice symptoms in people with spasmodic dysphonia (SD), a form of focal dystonia of 
the larynx. This is a cumulative doctoral dissertation. It consists of three separate 
projects. The first project investigated the short-term effect of vibro-tactile stimulation 
(VTS) in people with adductor SD. The second project represents a logical extension of 
the previous work by improving the previous wired VTS technology and making it 
wearable. To that effect, I have designed and developed a wearable non-invasive collar-
like device that applies VTS to the laryngeal muscles. For the final project, I used the 
wearable device developed in project 2 to examine the efficacy of VTS for treating voice 
symptoms in people with the abductor SD.  
Spasmodic dysphonia (SD) – a voice disorder 
Spasmodic dysphonia is a rare speech disorder (1 per 100,000 cases) developing 
spontaneously during midlife. The progression is gradual in the first year and then 
becomes chronic for life (Ludlow, 2011; Ludlow et al., 2008). The average age of the 
disorder's onset is between 30-50 years old (Enver and Pitman, 2020). SD is the third 
most prevalent type of focal dystonia after cervical dystonia (CD) and blepharospasm 
(Castelon Konkiewitz et al., 2002). It is more prevalent in women than men (Ludlow et 
al., 2008; Soland et al., 1996).  
Patients with SD typically have a strained or choked speech and report that it takes an 
exhausting effort for them to speak (Ludlow, 2011). The cause of SD is unknown, but it 
is considered a form of task-specific focal dystonia (FD), meaning that involuntary 
spasms of the laryngeal musculature occur during speech but not during other phonatory 
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(e.g., prolonging vowels) or non-phonatory tasks (e.g., breathing). (Ludlow, 2011; 
Ludlow et al., 2008; Pool et al., 1991).  
Types of spasmodic dysphonia 
There are two types of SD: adductor (AD), typified by uncontrolled vocal fold closure; 
and abductor (AB), characterized by uncontrolled vocal fold opening. AD type of SD is 
more predominant (at least 80%) and typically occurs during the voiced components of 
speech which are words starting with or containing vowels. Conversely, AB results in a 
breathy or prolonged speech during the unvoiced components of speech such as /h/, /s/, 
/p/, and /f/ (Ludlow, 2011; Van Pelt et al., 1994). AB patients struggle with the phonation 
onset after an unvoiced consonant (Van Pelt et al., 1994).  
AD SD and AB SD affect different laryngeal muscles (Hoffman et al., 2009). AD is 
associated with hypertonia of the thyroarytenoid (TA) muscle (Van Pelt et al., 1994), yet 
abnormal activation of the thyroarytenoid can also be observed in AB SD (Watson et al., 
1991). Symptoms in AB SD are thought to be associated with abnormal hyperactivity of 
posterior cricoarytenoid (PCA) or failure of the lateral cricoarytenoid (CT) or 
thyroarytenoid muscle contraction (Cyrus et al., 2001; Hoffman et al., 2009). In addition, 
Cyrus et al. found an asymmetrical activation between both sides of CT muscle in AB 
SD patients (Cyrus et al., 2001). However, Van Pelt investigated the laryngeal muscle 
activity during movement intervals between AB SD and AD SD and did not find any 
significant difference (Van Pelt et al., 1994). These studies suggest that although speech 
symptoms between AB and AD are different, the pathophysiological profiles of both 
forms of SD are overlapping and not distinct, which introduces challenges both in 




At present, there is no cure for SD. It does not respond to behavioral speech therapy. 
Current therapeutic options are limited and are mostly directly altering or obstructing 
laryngeal muscle action rather than blocking or altering abnormal cortical activity. 
The gold standard treatment for SD is local Botulinum toxin (BOTOX) injection to the 
laryngeal muscles, where the primary injection muscle in AD SD is TA and in AB SD is 
PCA (Ludlow et al., 2008). The effectiveness of Botox is temporary, and patients need to 
have periodic injections for an average of every 3 to 6 months. The dosage has a wide 
range across patients (Blitzer et al., 1998; Ludlow et al., 2008). Although Botox provides 
average symptom relief of 90% of normal function for AD SD(Blitzer et al., 1998), it is not 
well tolerated by all SD patients (Watts et al., 2004) and has minor or no effects on some 
patients, especially AB SD (Ludlow et al., 2008). 
Over the past decades, there have been several attempts for surgical treatment of 
spasmodic dysphonia, mostly focusing on AD SD (Enver and Pitman, 2020). One 
approach is selective laryngeal AD muscles denervation-reinnervation (SLAD-R) (G. S. 
Berke et al., 1999), where the result shows that 80% of patients with AD SD showed a 
decrease in symptoms leaving the rest of the patients with unsatisfactory results with a 
breathy voice. Another surgical approach is midline lateralization thyroplasty for AD SD 
to restrain the glottis overclosure during speech (Isshiki et al., 2000), although, the 
results of this surgical intervention is rather mixed. A novel surgical treatment is laser TA 
myoneurectomy that shows encouraging results (Schuering et al., 2020). However, after 
12 months past surgery, 45% of the patients observed voice deterioration and 
underwent a second surgical procedure. Another alternative potential treatment of SD is 
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deep brain stimulation (DBS). A case study showed that bilateral deep stimulation of 
ventral intermediate nucleus (VIM) of the thalamus might be a viable target for treatment 
of severe SD (Lyons et al., 2010). At this point, DBS is not an established intervention to 
treat the voice symptoms of SD.  
Neurophysiology behind spasmodic dysphonia 
The underlying neural mechanism of SD is not entirely understood, but it is known to 
involve structural and functional alterations in the basal ganglia–thalamo-cortical 
circuitry, the brainstem, and the cerebellum (Ludlow et al., 1995b; Samargia et al., 2014; 
Simonyan et al., 2013; Simonyan and Ludlow, 2010; Simonyan et al., 2008). The 
pathophysiology of SD is characterized by an abnormally high synchronous activity 
within and across cortical neural networks involved in voice production that is mainly 
lateralized in the left hemisphere (Khosravani et al., 2019a). In addition, SD, like several 
other forms of focal dystonia (FD), including cervical dystonia (CD) and blepharospasm, 
present with somatosensory system abnormalities even in non-dystonic muscles (Ali et 
al., 2006; Konczak et al., 2015; Maschke et al., 2003; Patel et al., 2014a; Putzki et al., 
2006). For example, abnormal blink reflexes were observed in SD, torticollis, and 
blepharospasm (Cohen et al., 1989; Tolosa et al., 1988; Topka and Hallett, 1992), and 
abnormal long-latency responses to peripheral nerve stimulation have been observed in 
SD (Ludlow et al., 1995a), in blepharospasm and oromandibular dystonia (Berardelli et 
al., 1985). Recent evidence from our group and the work of others strongly indicate that 
basal ganglia-related diseases such as Parkinson's disease and certain forms of 
dystonia are associated with somatosensory and specifically proprioceptive 
abnormalities that are closely linked to the observed motor deficits (Contreras-Vidal and 
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Gold, 2004; Demirci et al., 1997; Konczak et al., 2007; Maschke et al., 2003; Maschke et 
al., 2005; Patel et al., 2014b; Putzki et al., 2006).  
Somatosensory deficits in FD 
Numerous research reports documented somatosensory deficits in FD. For example, 
proprioceptive-based finger position sense thresholds and the perception of arm motion 
are abnormal in patients with cervical dystonia or blepharospasm (Grünewald et al., 
1997; Putzki et al., 2006). The abnormalities in tactile and proprioceptive processing are 
not restricted to the affected dystonic musculature but were also documented in non-
affected body regions (Fiorio et al., 2008; Molloy et al., 2003; Putzki et al., 2006), 
indicating a generalized somatosensory deficit in FD. Recording of somatosensory 
evoked potentials (SEPs) and TMS data document that abnormal processing of 
somatosensory information in FD is associated with abnormally enhanced cortical 
excitability and decreased intracortical inhibition (Kanovsky et al., 2003; Zeuner and 
Molloy, 2008), which also has been confirmed for SD (Samargia et al., 2014). In 
addition, there is convergent evidence that FD is associated with kinaesthetic deficits 
that are also manifest in non-dystonic musculature (Konczak and Abbruzzese, 2013; 
Putzki et al., 2006).  
Majority of individuals with SD experience abnormalities related to their limb movements 
(Pool et al., 1991). Recent work from our group confirmed upper limb proprioceptive 
deficits in SD (Konczak et al., 2015), demonstrating that, like other forms of FD, SD is 
associated with a generalized somatosensory deficit.  
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Somatosensory stimulation – a potential treatment approach 
The susceptibility of FD to somatosensory stimulation has long been known because 
patients with task-specific dystonia may use sensory tricks (geste antagoniste) to 
temporarily alleviate dystonic symptoms by touching or pressing areas of or near the 
dystonic musculature (Kägi et al., 2013; Poisson et al., 2012). Research on cervical 
dystonia documented that effective sensory tricks can ease dystonic symptoms and are 
associated with pallidal and motor cortical desynchronization at low frequencies (6-8Hz) 
(Tang et al., 2007).  
Moreover, studies on the effects of sensory stimulation of the larynx have indicated a 
reduced inhibition of laryngeal muscle responses to sensory stimulation, i.e., a reduced 
suppression of motor responses to laryngeal sensory stimulation (Ludlow et al., 1995a). 
Functional neuroimaging in SD during phonation has also shown increased central 
activation in the laryngeal somatosensory cortex in patients with SD (Simonyan and 
Ludlow, 2010). These studies highlight different forms of somatosensory abnormalities in 
SD, which may contribute to the pathomechanism of the disease. This notion opens an 
avenue for a potential behavioral treatment for SD that seeks to modulate the 
somatosensory information of the laryngeal musculature to improve the speech motor 
output. 
In particular, the vibro-tactile stimulation (VTS) of laryngeal muscles might be a suitable 
tool for this purpose, given that it is shown to alter the afferent proprioceptive signals 
produced by the vibrated muscle mechanoreceptors and muscle spindles (Bianconi and 
Van Der Meulen, 1963; Brown et al., 1967c).  
7 
 
Effects of vibro-tactile stimulation (VTS) 
It has long been established that VTS can stimulate muscle spindles (Bianconi and Van 
Der Meulen, 1963; Brown et al., 1967a, 1967b) and mechanoreceptors (Vedel and Roll, 
1982) affecting motor behavior and inducing changes in kinaesthesia (Goodwin et al., 
1972a, 1972b; Roll and Vedel, 1982). In general, vibrating the skin at amplitudes of ≤ 15 
µm is sufficient to activate Ia muscle spindle afferents of superficial muscles, which 
evokes a contractile response called the Tonic Vibration Reflex (Bianconi and Van Der 
Meulen, 1963; Brown et al., 1967b). To elicit kinaesthetic illusions, vibration must 
typically range between 40-100 Hz (Cordo et al., 1995; Cordo et al., 2005). Brief 
vibration to a relaxed muscle typically leads to an increase in muscle tone that can easily 
be overcome by voluntary phasic innervation (De Gail et al., 1966), while excitatory input 
to spinal α-motor neurons is depressed when vibration is applied for prolonged periods 
(Shinohara, 2005). At the cortical level, it has been shown that prolonged muscle tendon 
vibration of wrist flexors (30 min) induced an increase in corticospinal excitability of the 
antagonistic wrist extensors lasting up to 60 min after vibration, indicating that VTS can 
induce measurable changes in short-term cortical plasticity (Forner-Cordero et al., 2008; 
Steyvers et al., 2003).  
VTS can reduce the severity of dystonic postures in FD. Vibrating dystonic neck muscles 
of patients with torticollis, who exhibit abnormally tilted head postures, induced head 
righting, and nearly restored normal head posture (Karnath et al., 2000; Zhu, 2020). 
Vibrating non-dystonic arm muscles in patients with cervical dystonia and 
blepharospasm skewed arm position sense to a greater extent than healthy controls 
(Grünewald et al., 1997). VTS has been shown to influence somatosensory perception 
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and may reduce the severity of dystonic postures (Grünewald et al., 1997; Kägi et al., 
2013; Karnath et al., 2000; Konczak and Abbruzzese, 2013). 
Vibro-tactile stimulation as a potential treatment for SD 
No studies exist that investigated the effects of VTS in SD. There are several 
physiological similarities between the speech and limb motor systems that make VTS 
use plausible, but anatomical differences make the application of VTS more challenging. 
The knowledge on the distribution and function of somatosensory receptors within the 
laryngeal musculature is still inconclusive. A series of neuroanatomical, histochemical, 
and electron microscopic studies supported the existence of muscle spindles in the 
larynx (Baken and Noback, 1971; Grim, 1967; Hirayama et al., 1987; Paulsen, 1958; 
Tellis et al., 2004), while others failed to provide support for the existence of intrafusal 
muscle fibers in cricothyroid and thyroarytenoid muscles (Brandon et al., 2003) or could 
not elicit stretch responses in these areas (Loucks et al., 2005).  
Moreover, the mucosa of the epiglottis is known to have an array of mechanoreceptors 
responsive to mechanical stimulation between 10-70Hz with a depression amplitude of 
<100μm (Davis and Nail, 1987; Nagai, 1982). It was further demonstrated that the 
sensory basis for the laryngeal adductor response is dependent on the stimulation of 
mechanoreceptors in the laryngeal mucosa in the cat and humans (Andreatta et al., 
2002; Loucks et al., 2005). Further, the finding of Krause-type sensory corpuscles at the 
free edge of the vocal cords underlines the notion that many of these mechanoreceptors 
provide proprioceptive feedback not only useful for swallowing but for voice control 
(Nagai, 1982). In addition, it needs to be considered that Botox treatment may impair 
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responses of laryngeal muscle spindles in SD because their innervating γ-motor neurons 
are cholinergic. 
One challenge in applying VTS to the speech motor system is that intrinsic laryngeal 
muscles, and the mucosa of the epiglottis are shielded by thyroid cartilage. While 
proprioceptors of limb muscles can be stimulated by placing vibrators on the skin above 
them, this is not possible for laryngeal muscles. Thus, non-invasive vibrators are needed 
that can be easily attached to the skin above the larynx and vibrate with sufficient 
amplitude to induce responses in laryngeal mechanoreceptors. Many of the vibrators 
that have been used to investigate vibration responses in limb muscles are not suitable 
due to size, weight, and voltage requirements. Recent advancements in vibrator 
technology have produced small, low voltage, yet powerful vibrators that, for the first 
time, make it feasible to wear and operate vibrators at the neck for a prolonged time 
without restricting a person's movement. 
Given that SD, like other FDs, is associated with abnormally increased cortical excitation 
and heightened levels of neuronal synchronization (Samargia et al., 2014; Zeuner and 
Molloy, 2008), this work proposes that VTS can reduce sensorimotor cortical excitation 
in SD by desynchronizing motor cortical neuron activity as has been shown in cervical 
dystonia (Tang et al., 2007). 
Project rationale 
SD is associated with similar proprioceptive deficits as other forms of FD, and altering or 
modulating proprioceptive signals may be a way to normalize motor output. No data 
exist on how SD patients respond to VTS. New advances in vibrator technology make 
the application of VTS to stimulate laryngeal proprioceptors in SD feasible. The 
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neurophysiological mechanism behind the VTS efficacy in SD is based on the 
stimulation of laryngeal mechanoreceptors. 
The general aim of this dissertation is to provide scientific evidence that VTS represents 
a non-invasive form of neuromodulation that can induce measurable improvements in 
the speech of SD patients. This work seeks to address a clinical need to develop 
alternative or auxiliary treatments for a rare voice disorder with limited treatment options. 
In addition, this project introduces a novel new wearable vibrator technology that allows 
for the in-home and clinical application of VTS.
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Project 1: The Effects of one-time laryngeal vibration on 
cortical activation patterns and markers of voice quality 
in people with spasmodic dysphonia 
Recent work from our group confirmed upper limb proprioceptive deficits in SD (Konczak 
et al., 2015), confirming that a generalized somatosensory deficit is present in this 
disorder. This finding opens an avenue for a new and missing behavioral treatment for 
SD that seeks to alter or mask the faulty central processing of proprioceptive inputs to 
improve speech motor output. Laryngeal vibro-tactile stimulation (VTS) might be a 
suitable tool, given that it alters the afferent proprioceptive signals produced by the 
vibrated muscle spindles and mechanoreceptors (Bianconi and Van Der Meulen, 1963; 
Brown et al., 1967b). To further investigate the effect of VTS on patients with SD, a few 
questions need to be explored: 
• Can VTS provide measurable symptomatic relief for patients with SD? If so, is 
there any objective changes in the voice quality after VTS? 
• What are the changes in the cortical activity associated with VTS? 
Accordingly, this project sought to systematically evaluate the effect of laryngeal VTS on 
people with SD. The findings of this study would set the basis for taking a step toward 
developing a novel, non-invasive neuromodulation treatment for SD. 
Specific aims 
Aim 1: Demonstrate the effects of one-time laryngeal vibration on markers of voice 
quality in people with spasmodic dysphonia. 
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Aim 2: Demonstrate the effects of one-time laryngeal vibration on cortical activation 
patterns in people with spasmodic dysphonia. 
Methods 
Participants 
Thirteen people with SD (8 female, 5 male; mean age  std: 58.6  12.5 years) were 
recruited from the Fairview Clinic at the University of Minnesota and attended the study 
(See Table 1 for clinical characteristics of study participants). The experimental protocol 
was approved by the Institutional Review Board of the University of Minnesota. All 
participants gave their informed consent prior to the experiment. Patients receiving 
botulinum toxin (Botox) treatment were tested toward the end of their injection cycle to 




Table 1. Clinical characteristics of study participants. F: female, m: Male, R: Right 
Subject 
ID 
















SD 01 F 71 R ADD Moderate 44 4 9 
SD 02 F 48 R ADD No 48 4 3 
SD 03 M 59 R ADD No 40 4.5 4.5 
SD 04 M 60 R ADD No 50 >3 3 
SD 05 M 73 R ABD No 180 NA 36 
SD 06 F 57 R ADD Moderate 36 NA NA 
SD 07 F 62 R ADD 
Mild to 
moderate 
411 5 2 
SD 08 Male 26 R ADD No 93 2-5 2.5 
SD 09 F 65 R ADD 
Mild to 
moderate 
204 2 2 
SD 10 F 56 R ADD Mild 324 6 6 
SD11 F 57 R ADD No 15 3 3 
SD12 M 74 R ADD No 396 4 4 






As stimulators, we used a pair of light-weight encapsulated cylindrical vibrators (Pico 
Vibe, Precision Microdrives Ltd., London, UK) (See Figure 1). The vibration frequency 
for VTS was set to100Hz in this study. Preliminary work in our laboratory with healthy 
human volunteers showed that using these vibrators, a vibration frequency of 100Hz is 
capable of generating peaks in the power spectrum of the voice signal that is within the 
frequency range known to stimulate laryngeal mechanoreceptors in animals (Davis and 
Nail, 1987) or induce kinaesthetic illusions in humans, which are known to be based on 
muscle spindle input (Cordo et al., 1995; Cordo et al., 2005). Thus, we could reasonably 
assume that besides tactile receptors of the skin above the voice box, laryngeal 
mechanoreceptors were also stimulated.  
 
Figure 1. Final tested micro vibrators. Right: Coin vibrator (Ø 12mm; thickness: 3.4mm. Left: 
Encapsulated cylinder vibrator (length: 25mm; Ø 8.8mm). U.S. quarter coin for comparison. 
EEG data were recorded with the ActiveTwo data acquisition system (Biosemi B.V. Ltd, 
Amsterdam, Netherlands). The sampling rate was set at 512 Hz. Brain potentials were 
captured via Biosemi's 64-channel EEG cap with an equiradial system of electrode 
placement. Participants were guided throughout the experiment by a series of 250ms 
long auditory cues (1000Hz, 98dB) generated by RPvdsEx software (Tucker-Davis 
Technologies Ltd., Alachua, USA). The TDT system and RPvdsEx software were also 
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used to control the activation of the vibrators. The time-stamp of auditory cues and 
vibration onset/endpoint were captured simultaneously. 
Experimental Procedure and Behavioral Task 
The experiment took place in an electrically and acoustically shielded chamber at the 
Multiple Sensory Perception Laboratory at the University of Minnesota. Participants sat 
on a comfortable chair, asked to avoid extra movements and to focus their visual gaze at 
a fixation point on the front wall. The pair of vibrators was attached externally and 
bilaterally on the participant's neck over the laryngeal area (see Figure 2).  
 
Figure 2. Setup for the application of laryngeal VTS. The encapsulated cylindrical vibrators were 
attached to the laryngeal area of the neck, laterally to the thyroid cartilage. 
Prior to the experiment, the severity of speech symptoms was evaluated by (1) reading a 
series of standard sentences (Woodson, 2010) devised for the evaluation of voice 
quality in AB/AD spasmodic dysphonia (For the list of sentences, see Appendix I); and 
(2) pronouncing vowel /a/ three times, each lasting four seconds. All speech and voice 
signals were recorded for later offline analysis.  
The experimental protocol comprised two blocks: (1) laryngeal vibration (VTS Only), and 
(2) vowel vocalization accompanied by laryngeal VTS (Vocalization + VTS). During the 
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VTS Only condition, the laryngeal vibrators were alternately turned on and off (3 
seconds ON following 3 seconds OFF) for 50 repetitions and then stayed ON 
continuously for the final 3 minutes. During the Vocalization + VTS condition, participants 
received an auditory cue (1000Hz, 98dB) for 250ms and then vocalized the vowel /a/ 
continuously for 4 seconds. During the second half of the vocalization period, laryngeal 
VTS was applied. Participants stopped vocalization with the cessation of laryngeal VTS. 
This procedure was repeated 50 times with 4-second long resting intervals in between. 
Both conditions were applied in two sets, with each set lasting 17 minutes. Between 
sets, at the end of set 2, and 20 minutes after the cessation of VTS (Retention), 
voice/speech quality was evaluated using the same assessment tasks given at Baseline 
(see Figure 3). 
 
Figure 3. The experimental protocol for the project I 
Speech Quality Measures 
Participants read two sets of standard sentences (Woodson, 2010) for the speech 
evaluation of people with adductor and abductor SD in their normal conversational style 
(See Appendix I). Assessment of these recorded voice data was performed offline. Two 
voice measures were obtained: (1) the number of voice breaks and (2) the change in the 
cepstral peak prominence (CPP) of voice (Fraile and Godino-Llorente, 2014).  
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CPP is an acoustic measure of speech quality defined as the logarithm of the Fourier 
Transform of the signal's power spectrum and reveals the degree of regularity in the 
voice data. Three unit change in CPP in a positive direction is indicative of a meaningful 
improvement in voice/speech quality. CPP is considered one of the most reliable 
measures of dysphonia severity (Maryn et al., 2009). Here, we employed a smoothed 
cepstral peak prominence technique, referred to as CPPs, in which the individual cepstra 
are smoothed before extracting the peak and computing the peak prominence 
(Hillenbrand and Houde, 1996). At first, all speech signals were broken and labeled into 
'voiced' and 'unvoiced' segments. Then, CPPs values were derived only for the 'voiced' 
periods. The PRAAT software was used for the acoustic analysis of the voice data. 
EEG signal processing 
The EEGLab toolbox of MATLAB (The MathWorks, Natick, MA) was used for exploring 
the EEG data (Delorme and Makeig, 2004). The EEG signal processing steps were as 
followed: 
1. The averaged signal of the two external electrodes embedded over bilateral 
mastoid bones was used to reference all electrodes.  
2. The data were high-passed filtered at the cut-off frequency of 1Hz to address 
possible baseline drifts using a zero-phase FIR filter. A zero-phase notch filter 
was used to remove power line noise.  
3. In order to weaken the potential effect of non-cortical sources that might have 
been commonly captured by electrodes, each channel was re-referenced to the 
common average of all electrodes. 
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4. Segments of EEG recordings from 1000ms before audio cue to 4000ms after the 
onset of vocalization were extracted as data epochs. The 1000 ms period prior to 
the audio cue was used as the baseline (resting state) for the cortical activity. 
5. We subsequently used the 'runica' algorithm to perform independent component 
analysis (ICA) on all data channels. ICA is a method to decompose independent 
sources that are linearly mixed. 
6. An automated multiple artifact rejection algorithm, 'SASICA' (Chaumon et al., 
2015) implemented on the resultant components to identify and remove the 
contaminated ICs. This algorithm recruits spatiotemporal criteria to distinguish 
the artifactual components. This is critically important for the identification and 
removal of muscle artifacts that may have contaminated the EEG data during 
vowel vocalization.  
7. Finally, the remaining ICs were linearly summed up, and the output dataset was 
used for extracting the features. 
Electrocortical measures 
As a primary EEG measure, we obtained the event-related spectral perturbation (ERSP) 
of somatosensory-motor cortical electrodes in response to VTS. ERSP measures the 
average time course of relative changes in the spontaneous EEG amplitude spectrum 
induced by a set of similar experimental events, which in this project is Vocalization and 
VTS. ERSP presents the logarithm of the mean event-related alteration in spectral 
power relative to the resting state at each frequency bin (Makeig, 1993).  
To calculate the ERSP, the average baseline spectral power was calculated for each 
trial. Then, the spectral power of each trial was divided to the average baseline to 
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normalize the response. Finally, the spectral power of all trials was averaged to compute 
the ERSP. In addition, a two-tailed permutation significance probability was be 
performed to measure the significant difference to the baseline power. In our 
assessment, the significance level was set as 0.05. 
Band-specific features were separately extracted for the physiologically-relevant 
frequency ranges (i.e., <50Hz): theta (4-8Hz), alpha (8-13Hz), beta (13-30Hz), and the 
low gamma (30-49Hz). ERSP was extracted for six sites: CP5, C5, FC5, CP6, C6, and 
FC6 (See Figure 4). CP5 and CP6 were nearby bilateral somatosensory cortical areas. 
C5 and C6 were nearby bilateral motor cortical areas. FC5 and FC6 were nearby 
bilateral premotor cortical regions. Indices' 5' and '6' reflect the cortical areas close to 
bilateral vocalization regions over somatosensory and motor homunculi (Caviness et al., 
2006; Mor et al., 2018). 
 
Figure 4. Position of cortical electrodes of the EEG cap. Somatosensory (CP5 and CP6), motor 
(C5 and C6), and premotor (FC5 and FC6) for left and right hemispheres, respectively. 
As a secondary EEG measure, we obtained the event-related coherence (ERCOH) 
between pairs of somatosensory-motor cortical electrodes as an indicator of the level of 
synchrony between the two electrodes (Pfurtscheller and Andrew, 1999). ERCOH was 
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derived for CP5-FC5 and CP6-FC6 electrode pairs. Before the computation of ERCOH, 
EEG epochs were pre-whitened to exclude possible autocorrelations/trends that might 
interfere with the data.  
EEG features were extracted from the Vocalization + VTS conditions of both sets (see 
Figure 3) to investigate the immediate cortical response to VTS. For each condition, the 
4000ms long trials were divided into two segments:  
1) VTS-off (before the onset of laryngeal vibration) – Only Vocalization. 
2) VTS-on (after the onset of laryngeal vibration) – Vocalization and vibration. 
For each participant, the ERSP measure of the average of the 50 recorded epochs was 
derived separately for the VTS-off and VTS-on segments. Because the first 500ms of the 
VTS-off period additionally contain cortical auditory evoked potentials (Alvarenga et al., 
2013) or be influenced by the reaction time of the study participants (Santee and 
Kohfeld, 1977), the first 500ms of vocalization were excluded from further EEG analysis 
(i.e., the VTS-off interval was defined between 500-2000ms after the presentation of the 
auditory cue).  
Statistical analysis 
For SD1 to SD3, no EEG data were available. Statistical comparisons of the pre- versus 
post-VTS cortical potentials were performed on the available EEG data of 10 
participants. The Kolmogorov-Smirnov test was implemented to examine the normality of 
the data. Since the distribution of the data was not normal, the non-parametric Wilcoxon 
sign rank test was used for statistical assessments. For each frequency band and the 
group of electrodes covering each hemisphere, p-values were adjusted for multiple 
comparisons using the Benjamini-Hochberg method (Benjamini and Hochberg, 1995). 
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The significance level was set at p-value = 0.05. The effect size was calculated using 
Cohen's d.  
Results 
Changes in markers of speech quality 
We recorded the voice of 13 SD participants as they read a list of sentences devised for 
the speech evaluation of SD (Woodson, 2010) at four different time stamps along with 
the experimental protocol (see Figure 3):  
1) Pretest (Baseline): Prior to VTS; 
2) Post-test 1: After 14.7 minutes of VTS; 
3) Post-set 2: after 29.4 minutes of VTS; 
4) Retention: 20 minutes past the cessation of VTS. 
Subsequently, we derived the number of voice breaks and CPPs as measures of speech 
quality from the acoustic signal. The clinical and self-perceived markers of speech for 
the Pretest show that participants experienced different levels of voice symptom 









Self-Rated Effort Scale 
(ADD/ABD Sentences) 
Self-Rated Effort 
Scale (Vowel /a/) 
SD 01 5 4 7 
SD 02 4 3 2 
SD 03 0 2 3 
SD 04 0 2 3 
SD 05 12 3 2 
SD 06 9 5 7 
SD 07 0 4 5 
SD 08 2 7 6 
SD 09 4 9 8 
SD 10 2 2 2 
SD 11 0 2 3 
SD 12 0 2 2 
SD 13 0 3 3 
Nine out of 13 participants (69%) responded to VTS and showed a reduction of the 
number of voice breaks and/or a rise of CPPS (> +1dB) at Post-set 1 and/or the Post-set 
2 as compared to Pretest. The remaining four participants did not show a consistent 
response to VTS as quantified by a rise in CPPS. It is noteworthy that none of the non-
responding patients exhibited voice breaks at Pretest (see Figure 5; bottom panels). 
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Improvements in both speech quality measures for the responders were preserved at 
the retention stage (see Figure 5; top panels). As a group, participants showed a 
significant rise of CPPS after 14.7 minutes of laryngeal VTS in comparison to their 
Pretest (p = 0.02, d = 1.06), which was retained at 20 minutes past the last application of 
VTS (p = 0.006, d = 1.15; see Figure 5). The corresponding effect sizes were large 
(Cohen's d > 0.8) at both time stamps. In addition, 6 out of 7 SD participants (86%) who 
exhibited voice breaks at Pretest showed a reduction of voice breaks in response to 
laryngeal VTS, with four patients having no voice breaks after 14.7 minutes of VTS (see 




Figure 5. Change in the number of voice breaks and CPPs as at different stages of VTS 
application (Pretest, Post-set1, Post-set2, and Retention). Responders to VTS are shown in the 
top graphs, non-responders in the bottom graphs). Note that all non-responders exhibited no 
voice breaks prior and during VTS. Typically, responders showed improvements in both markers 
of voice/speech quality. Note that SD 5 showed no effect in CPPs, but drastically reduced the 




Table 3. VTS induced change in smoothed cepstral peak prominence (CPPS) and the number 








SD1 (-0.34, -5) (0.53, -4) (0.78, -5) 
SD2 (0.15, -4) (0.60, -4) (0.47, -4) 
SD3 (0.63, 0) (-1.50, 0) (-0.37, 0) 
SD4 (2.35, 0) (2.15, 0) (1.45, 0) 
SD5 (-1.13, -2) (-1.33, -10) (0.2, -9) 
SD6 (2.33, -9) (1.98, -9) (2.34, -9) 
SD7 (1.10, 0) (4.08, 0) (2.81, 0) 
SD8 (2.27, +3) (1.40, +4) (0.45, -1) 
SD9 (0.56, 0) (0.41, -3) (1.50, -) 
SD10 (0.71, -2) (0.56, -1) (0.55, -1) 
SD11 (0.58, 0) (0.29, 0) (0.12, 0) 
SD12 (0.38, 0) (-0.01, 0) (0.07, 0) 




Change in the cortical oscillatory behavior in response to laryngeal VTS 
The effect of VTS on cortical oscillatory activity over somatosensory and premotor cortex 
resulted in an almost immediate suppression of low-frequency oscillations as illustrated 
in an exemplar time-frequency plot of one SD participant in Figure 6. 
 
Figure 6. Effect of laryngeal VTS on bilateral right somatosensory and premotor cortical ERSP 
for VTS-off (0-2000ms) versus VTS-on (2000-4000ms) in a single patient. Note that laryngeal 
VTS resulted in the event-related desynchronization of low-frequency oscillations over 
somatosensory-motor cortical areas in both hemispheres (see dashed ellipses) (From Khosravani 
et al., 2019b). 
For the complete patient sample, the application of VTS during the first 14.7 minutes 
(Set 1; see Figure 3) induced a significant event-related desynchronization of cortical 
theta-band oscillations over the left somatosensory, motor, and premotor cortex (C5: p = 
0.049, d = 0.82; CP5: p = 0.049, d = 0.47; FC5: p = 0.049, d = 0.65; see Figure 7, top 
panels), and a significant immediate rise of the somatosensory and motor cortical 
gamma power over the right hemisphere: (C6: p = 0.037, d = 0.48; CP6: p = 0.037, d = 
0.39; FC6: p = 0.029, d = 0.51, see Figure 7, top panels). After participants had received 
VTS in Set 2, a similar pattern of cortical activity emerged. It again resulted in a 
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significant desynchronization of theta oscillations over the left motor cortical area (C5: p 
= 0.012, d = 0.83), and a significant rise of gamma oscillations over the right 
somatosensory-motor cortical regions: (C6: p = 0.015, d = 0.38; CP6: p = 0.027, d = 
0.36; FC6: p = 0.015, d = 0.47; see Figure 7, bottom panels).  
 
Figure 7. Effect of VTS on ERSP over somatosensory and motor cortical areas for theta and 
gamma bands during Vocalization. Boxplots reflect the data for all subjects during the two sets of 
VTS (see Fig. 1B for the timing of the sets). Left panels: Theta band ERSP for left 
somatosensory (CP5), motor (C5), and premotor (FC5) cortical electrodes after the first and 
second set of VTS. Right panels: Gamma band ERSP over right somatosensory (CP6), motor 
(C6), and premotor (FC6) cortical electrodes after the first and second application of VTS. The 
boxplots represent the distribution of individual ERSP values within each group. The lower and 
upper boundaries of each box depict the 25% and 75% quartiles, respectively. The horizontal line 
within the box indicates the median. The upper and lower whiskers extend to +1.5 and -1.5 
interquartile range, respectively. Outliers are shown as white circles. * indicates a p-value of < 
0.05 (From Khosravani et al., 2019b). 
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There were no significant changes of theta spectral power over the right hemisphere or 
of gamma-band power over the left hemisphere. Similarly, assessment of ERSP in other 
frequency bands (alpha and beta) did not reveal any significant changes pre- versus 
post-VTS for any of the electrodes over left/right hemispheres (all p's> 0.05).  
We also performed a Pearson's correlation analysis between the change in behavioral 
markers of voice quality (CPPS or the number of voice breaks) and theta/gamma ERSP 
for all participants collectively (responders and non-responders). No significant 
correlational relationships were observed. We then repeated the same analysis only on 
the responder group for whom either a rise in the CPPS or a decline in the number of 
voice breaks was observed (SD1, SD2, SD4, SD5, SD6, SD7, SD8, SD9, SD10). Again, 
no significant relationships were found. 
A subsequent coherence analysis examined potential differences in the spectral 
characteristics of somatosensory-motor cortical interactions in each hemisphere. This 
analysis found no evidence that laryngeal VTS significantly affected the inter-regional 
spectral coherence between somatosensory and motor cortical areas within each 
hemisphere (all p's> 0.05).  
Discussion 
The goal of this study was to explore whether laryngeal VTS can provide benefits for 
patients with SD by monitoring its short-term effects on voice quality and the associated 
activity over laryngeal somatosensory-motor cortical areas. The main findings of this 
research are as follows:  
First, a one-time application of laryngeal VTS resulted in the significant improvement of 
two standard measures of voice/speech quality in 69% of the patients. The effect 
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persisted for at least 20 minutes after the cessation of VTS. What seemed to 
discriminate the "responders" from those participants, who received little to no benefits 
from VTS, was that "non-responders" were more mildly affected and had no voice 
breaks prior to receiving VTS (see Figure 5). 
Second, the application of laryngeal VTS induced an immediate significant suppression 
of theta band synchronization over the left somatosensory-motor cortex and the 
immediate significant rise of gamma-band synchronization over the right somatosensory-
motor cortical region.  
Possible mechanisms behind the effectiveness of laryngeal VTS for 
improving speech in SD 
An abnormal kinaesthetic function has been reported in non-dystonic limbs and muscle 
systems in SD (Konczak et al., 2015) and other forms of focal dystonia such as 
blepharospasm and cervical dystonia (Putzki et al., 2006). This implies that a more 
generalized somatosensory deficit underlies or is associated with the focal motor 
dysfunction in dystonia. Here, we explored if modulating somatosensory inputs could 
provide an avenue for a missing behavioral treatment for SD. Our approach of applying 
VTS constitutes a form of non-invasive neuromodulation that alters the output of afferent 
proprioceptive and tactile mechanoreceptors (Bianconi and Van Der Meulen, 1963; 
Brown et al., 1967c), which is then centrally processed. Among the prominent 
neuropathological features of dystonia are reduced neuronal discharge rates and altered 
discharge patterns within the basal ganglia-thalamo-cortical motor circuitry (Vitek, 2002). 
Invasive neuromodulation techniques, such as deep brain stimulation, attempt to 
normalize the irregular neuronal discharge patterns by applying high-frequency impulses 
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to targeted subcortical nuclei (Hendrix and Vitek, 2012; Johnson et al., 2008) with the 
aim to restore the activity of upstream motor cortical networks. Here we suggest that a 
non-invasive high-frequency peripheral stimulation via laryngeal VTS may similarly 
modulate the discharge patterns of neurons in the somatosensory-motor speech network 
(Ludlow, 2015), which can positively affect the speech motor output in SD.  
Modulation of cortical oscillations in response to laryngeal VTS 
We recorded EEG signals to understand how laryngeal VTS affects cortical activity in 
SD. We found that in our sample of SD participants applying laryngeal VTS was 
associated with a significant suppression of theta-band power oscillations over the left 
somatosensory-motor cortex and a significant rise of gamma rhythm over right 
somatosensory-motor cortex (see Figure 7). Theta oscillations are detectable in a 
number of brain nuclei, including the striatum (J. D. Berke et al., 2004; Goto and 
O'Donnell, 2001). Previous research identified abnormal theta oscillations at subcortical 
and cortical levels in other forms of focal dystonia, such as cervical dystonia (Liu et al., 
2002; Liu et al., 2008). These abnormal theta oscillations in globus pallidus internus 
significantly correlate with the severity of symptoms in cervical dystonia (Neumann et al., 
2017).  
The susceptibility of focal dystonia to somatosensory stimulation has long been 
recognized as patients with task-specific dystonia may use sensory tricks (geste 
antagoniste) to alleviate dystonic symptoms temporarily by touching or pressing areas of 
or near the dystonic musculature. The neurophysiological correlate of an effective 
sensory trick is the suppression of abnormal cortical theta oscillations in CD (Tang et al., 
2007). The similarity between our EEG finding of suppressed theta band power in SD 
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and the one reported for patients with CD (Tang et al., 2007) suggests that the 
improvement of abnormal speech motor output in SD via laryngeal VTS may activate the 
same neurophysiological mechanism underlying an effective sensory trick in CD.  
Another identified feature of modulated sensorimotor cortical processing due to VTS was 
the rise of gamma rhythm over the right somatosensory-motor cortex. Gamma band 
oscillations are believed to form through the activation of excitatory pyramidal neurons 
and inhibitory interneurons regulated by the GABA-mediated synaptic current (Nowak et 
al., 2018). The synchronization of gamma oscillations underlies task-specific functions 
such as somatosensory processing (Bauer et al., 2006) and motor preparation (Engel et 
al., 2001; Nowak et al., 2018). Gamma activity in the 40Hz range has been detected 
during speech (Palva et al., 2002). Movement-induced changes in gamma amplitude 
seem to reflect of the processing of afferent proprioceptive feedback in motor cortex 
(Miller et al., 2010; Muthukumaraswamy, 2010). Moreover, a rise of subcortical gamma-
band synchronization correlates with the amplitude and velocity of hand movements, 
highlighting its involvement in the neural control of movement (Brücke et al., 2012). 
Given the empirical evidence showing that cortical gamma-band activity underlies 
volitional motor control, our finding of a VTS-induced rise of gamma oscillations cortical 
areas involved in voice and speech motor control indicates that laryngeal VTS alters 
information processing within speech cortical networks, which positively influences the 
voice quality of people with SD. 
Limitations of the study 
This study yielded initial evidence that laryngeal VTS can improve voice symptoms in 
SD. The main limitation of this study is the lack of a control SD group that would allow for 
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the systematic examination of possible confounding placebo or practice effects. 
Although we cannot exclude the possibility that the observed improvements in voice 
symptoms constitute a placebo effect, we know from our pilot work that attaching the 
vibrators to the skin above the voice box (without being turned on) does not improve 
voice quality in SD. That is, it is unlikely that mere tactile stimulation would suffice in 
reducing voice symptoms. Moreover, there are no reports indicating that touching the 
neck constitutes a widely used and effective sensory trick in SD. In addition, the 
observed improvements in voice quality are not explained as a Hawthorne or special 
attention effect. On the contrary, as these patients were tested in their symptomatic 
stage when speech production is exhausting and effortful, one would expect that 
repeated vocalization and speech over more than 30 minutes results in a decline of 
speech, which we did not observe. Participants had not practiced the relevant test 
sentences prior to testing, nor is there evidence that voice symptoms in SD subside with 
repeated and prolonged speech. Finally, the effects on speech were observed when 
VTS was not applied. We recorded speech always after the end of each set of VTS (see 
Figure 3). In addition, the positive effects on markers of speech lasted for 20 minutes 
after the cessation of VTS.  
Another limitation is that while this study provided an insight into the improvement of 
voice symptoms in SD, most participants (except SD05) were diagnosed with ADD SD. 
Although the participant with AB SD (SD05) showed improvement in voice quality (See 
Table 3 and Figure 23), a more systematic effort to study the effect of VTS on patients 
with AB SD is needed. Project 3 of this dissertation addressed this knowledge gap and 
examined the effect of laryngeal VTS on the voice quality and cortical activation of 
patients with AB SD. 
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A different drawback concerns the lack of an objective established clinical scale to 
classify disease severity. Understanding why and how disease severity interacts with 
laryngeal VTS could be very useful in predicting who would respond well and would 
likely be a non-responder to VTS. We choose CPPS and the number of voice breaks as 
prominent predictors of SD severity (Peterson et al., 2013). The inclusion of other 
outcome measures such as the consensus auditory-perceptual evaluation of voice 
(CAPE-V) (Kempster et al., 2009) may provide additional markers for examining the 
effectiveness of laryngeal VTS. In summary, obtaining additional outcome measures to 
characterize disease severity in SD and then testing the effects of VTS in a larger 
sample of SD patients would be clinically meaningful in understanding who responds 
well to laryngeal VTS and who will likely not benefit from this treatment.  
Conclusions 
This is the first study that investigated the effect of laryngeal VTS on SD voice 
symptoms. Its results lay the scientific foundation for a randomized clinical trial to 
examine the usefulness of the approach in a larger patient sample and document the 
longitudinal changes in voice quality and the underlying cortical responses to laryngeal 
VTS in SD. Such clinical trials must address the shortcomings of this feasibility study. Its 
results should solidify our knowledge on the effectiveness of VTS for treating the voice 
symptoms in SD.  
The current study showed that the application of laryngeal VTS could result in 
meaningful improvements of speech quality in SD. Laryngeal VTS induced a significant 
suppression of theta band power over the left somatosensory motor. Similar suppression 
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of theta oscillations is observable in cervical dystonia patients applying effective sensory 
tricks, suggesting that VTS in SD may activate a similar neurophysiological mechanism. 
Disclaimer: The lead investigator of this project was Sanaz Khosravani, who is also the 
first author of the relevant publication. My role in this project was participant recruitment 
from Fairview Clinic at the University of Minnesota, assembling vibrators and preparing 
data collection procedures, EEG and auditory data collection, EEG data analysis and 
interpretation, and presenting the results in scientific conferences and meetings. 
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Project 2: Design and development of a wearable non-
invasive device for treatment of SD 
The results of project I showed convincingly that VTS represents a non-invasive form of 
neuromodulation that induces measurable improvements in the speech of SD patients. 
The limitation of the vibration technology that was implemented in the project I was that 
the participant was tethered to a device via cables that provided the power to control the 
vibrators. This limits the application of the VTS to only stationary settings. Accordingly, 
the next logical step to expand on the previous work was to improve on the VTS 
technology and to make it wearable. To that effect, I have designed and developed a 
wearable non-invasive collar-like device that applies VTS to the laryngeal muscles. 
Today, powerful vibrators are so small that they can be securely attached to bodily 
surfaces like the skin above the thyroid cartilage. In addition, voltage requirements to 
operate these vibrators are low, making battery-operated vibrators a reality in every cell 
phone. This project exploited this new vibrator technology to develop a non-invasive 
wearable device using lightweight, low-voltage, and low-cost vibrators to apply laryngeal 
VTS. 
Developing a wearable device with an ergonomic and anatomically correct enclosure for 
the electronics poses several challenges, for example: 
• The materials cannot be rigid.  
• The enclosure needs to be flexible to accommodate a user’s anatomical 
variability of the neck. It must align closely to the larynx (voice box) of each 
individual user because the vibrators need to be in constant contact with the skin. 
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• The device should be light-weight, battery-operated, and controllable via a 
wireless connection with either a computer or smartphone-based app. 
• Users should be able to wear it freely during the day. It can be removed as easy 
as a bracelet. 
• The device needs to employ robust speech detection technology to provide a 
targeted VTS only during the speaking task as a symptomatic stage in people 
with SD. 
• The computational cost of the speech detection algorithm must be minimal. 
Accordingly, this project aims to develop an innovative technology that allows for both in-
home and clinical application of VTS beyond a controlled laboratory environment. 
Specific aims 
Aim 1: Design and develop a wearable non-invasive device for applying VTS to the 
laryngeal musculature behind the thyroid cartilage as a symptomatic treatment 
for the voice disorder spasmodic dysphonia. 
Aim 2: Incorporate speech detection technology as a function of the device to activate 
the vibration only during the speaking task, which is the specific symptom of 
people with spasmodic dysphonia. 
Aim 3: Conduct a prototype bench testing to evaluate both the functionality and usability 
of the device on a subgroup of people with spasmodic dysphonia. 
Device description 
The complete system consists of three components: 
1) A flexible printed circuit board (PCB) that embeds the electronics, 
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2) A collar made of soft, wear-resistive, and washable textile materials, and 
3) Operating software to control the sensors, vibrators, and power. 
Electronic circuitry 
To address the ergonomic and individual anatomical characteristics of the neck of each 
user, we employed a flexible printed circuit board (PCB) technology. This thin PCB 
enclosure contained all the microcontrollers and sensors that are required for the VTS 
application (See Figure 8). The electronic hardware of the device consists of the 
following: 
• A Bluetooth module (model HC-05) enclosed in the PCB for sending real-time 
data to an external control unit which is a computer or a smartphone.  
• The circuitry has two sensors for recording real-time data as an input to the 
speech detection algorithm; A) a high sensitivity electret condenser microphone 
(model B4012AP422-003) is embedded in the PCB, and Ban accelerometer 
(model BU-23842-000) is connected to the PCB via a socket. The accelerometer 
needs to be attached to the user's neck to record the neck surface vibrations as a 
mean for detecting speech in real-time. 
• Two rechargeable lithium batteries (3.7V, 290 mAh) serve as a power supply 
obviating the need for a wired power supply. The batteries are connected to the 
PCB via a power socket. 
• An ARM microcontroller (model STM32F405RGT6) manages power 
consumption, controls the vibrators, and communicates with the control unit via 
Bluetooth module. The microcontroller tunes the vibration frequency and 
magnitude by changing the duty cycle of the PWM pulse. 
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• Two encapsulated micro-vibration DC electric motors (Precision Microdrives 
Type 307–100) are connected to the PCB board via a socket. Each vibrator can 
be moved 4 cm horizontally to accommodate variable neck anthropometry. 
• A Micro-USB B port is connected to the PCB for charging the batteries and 
providing power to the microcontroller. 
• A sliding single pole single throw switch is attached to the PCB to turn on/off the 
device manually.  
 
Figure 8. The developed flexible PCB. The dimension of the PCB board is w x h 4.2 x 15 cm. 
Vibrators and batteries are connected to the board via specific sockets. Accelerometers are not 
shown in this figure.  
Cloth Collar  
The electronic circuitry is inserted in a pouch of a soft and wear-resistive textile collar 
(See Figure 9B). The electronic enclosure can be removed from the textile collar so that 
the collar can be cleaned separately. The collar consists of the following:  
• Cover: soft, wear-resistive spandex fabric (82% Nylon, 18% Spandex) (See 
Figure 9A)  
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• Spacer: Neoprene scuba fabric (90% polyester and 10% spandex). The 
spacer stiffens the cover shell so that it can hold the batteries and vibratos in 
place. The PCB sits between the spacer and the inner side of the cover shell 
(See Figure 9B). 
• Elastic Strap: The inner side of the strap is coated with a Silicone layer that 
provides friction and will function as a gripper to hold the vibrators, PCB board, 
and batteries in place (See Figure 9B). 
• Invisible Zippers: Opens the pouch of the collar to insert the electric circuitry. 
• Two Velcro straps: attached to the outside shell of the spandex cover to strap 
the collar around the neck. 
• Microphone location mark: A red thread was sewed on the inside of the cover 
to indicate the microphone's location. The users must align this mark to the 




Figure 9. Textile collar (Dimension W x H 4.5 x50 cm). A) Cover of the collar. The collar will be 
worn around the neck of the user, while the microphone locator mark needs to be located in the 
center of the larynx. B) Inside of the collar pouch. PCB, vibrators, and batteries are held in place 
using elastic grips. Vibrators can move up to 4 cm horizontally to accommodate different neck 
anatomies. 
Operating software 
The device is developed to accommodate different scenarios that a user might need to 
employ laryngeal VTS. One scenario is the application of VTS for a limited duration (e.g., 
before attending an important meeting). Another scenario is applying VTS in real-time 
during speech (e.g., when giving a verbal presentation). As such, the device has two 
operational modes (See Figure 10): 
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1) Continuous VTS. User can turn on the device to receive VTS for a limited 
duration of their choice (e.g., 10 min) at a specified frequency. The device will 
automatically turn off the vibrators at the end of the chosen period. 
2) Real-time VTS. The device only activates the vibrators during the user’s speech. 
Using built-in sensors, Microphone, or an accelerometer, the device records the 
voice data and processes them in real-time. Once the speech detection algorithm 
identifies the real-time data as a voiced segment, vibrators will be automatically 
turned on. The frequency of the VTS can be specified via the user’s input. The 
default vibration is set to 100 Hz.  
Switching between two operational modes can be executed by the control unit via 




Figure 10: Schematic device function. The system has two operational modes: Continuous VTS 
and Real-time VTS. The control unit sends an order to the device to switch between the two 
operational modes. 
Speech detection procedure 
Most speech analysis research focuses on populations with healthy speech production. 
However, challenges with voice detection are exacerbated in dysphonic patients due to 
the strained speech produced, often at a much lower volume than is normal for the 
healthy population. As dysphonia severity increases, the effectiveness of microphone-
based measures decreases (Hillman et al., 2006). Some devices, like the Ambulatory 
Phonation Monitor (Cheyne et al., 2003), have been tested in SD population and 
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resulted in satisfactory outcomes. However, while existing devices are able to utilize 
either amplitude or frequency based algorithms for speech detection, none have done so 
with concurrent VTS in the vicinity of the microphone and accelerometer, as this study 
proposes. The introduction of VTS adds noise to the recording, which could interfere 
with the existing speech detection techniques. The second aim of project II is to develop 
a signal processing algorithm for real-time speech detection and implementation of VTS 
during the speech task.  
One basic, computationally efficient measure to characterize a signal for speech 
detection is signal power in the time domain. Power, P, of a discrete-time signal is 





∑ |𝑥(𝑛)|2𝑁−1𝑛=0                              (1) 
To differentiate speech signals from no activity using the signal power requires setting a 
threshold value. In case the signal power is above the threshold, the voice interval will 
be assigned as a speech frame. 
Threshold calculation 
There are two methods for assigning the threshold that have been implemented in the 
device: A) Manual input, where the user sends the threshold value to the device using 
the control unit, and B) Automatic threshold calculation. 
The steps for automatic threshold calculation are as follows (see Figure 11): 
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1) A 30 seconds audio signal in which the user will be asked to remain silent will be 
recorded using the embedded sensors in the device. The recording will be 
temporary stored in the device. 
2) The 30-second interval will be divided into 50-millisecond subintervals. 
3) Each subinterval signal will be filtered using a zero-phase bandwidth FIR filter 
(80 – 600 Hz, Order =20). 
4) The signal power will be calculated for each subinterval. 
5) The average signal power of all subintervals will be computed, which is then 
defined as the threshold for speech activity (see Figure 11). 
 
Figure 11. Threshold calculation flowchart. A 30000-ms interval of the baseline trial will be 
divided into 50-ms subintervals. The subintervals will be filtered, and their signal power values for 
each of these subintervals will be calculated. The power values will be then averaged together to 
calculate the threshold for speech activity. 
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Speech detection algorithm 
The speech detection algorithm is required for targeted real-time VTS during the speech. 
The developed algorithm introduces a 200-millisecond interval as a delay before the 
onset of VTS. The signal of the implemented delay period will be processed in the 
speech detection algorithm to determine whether it is a voiced or not voiced interval. The 
determination procedure is as follows (See Figure 12): 
1) The 200-millisecond interval will be divided into four 50 millisecond subintervals. 
2) Each subinterval will be filtered using a zero-phase bandwidth FIR filter (80 – 600 
Hz, Order =20). 
3) The power of each subinterval will be calculated. 
4) Signal power will be compared to the threshold to determine if it is above the 
threshold value. 
5) If any two contiguous subintervals have greater signal power than the threshold, 
the entire 200-millisecond interval will be considered voiced. 
6) The device will turn on the vibrators for the interval duration (200 milliseconds). 
7) Whether the interval is classified as a voice on not voiced, the next interval will 




Figure 12. Speech detection Algorithm: The 200-millisecond interval will be divided into four 
subintervals of 50 milliseconds. If two contiguous subintervals have a signal power greater than 
the threshold, the entire interval will be considered as voiced. 
Collar usability assessment 
In order to check the functionality and usability of the device, we have developed a 
survey (see Appendix II) and recruited a subset of individuals with SD to wear the device 
and provide feedback by responding to the survey. 
Methods 
Participants 
Five people with SD (5 female; mean age  std: 53  13.2 years) were recruited to 
participate in the study (See Table 4 for clinical characteristics of study participants). 
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The experimental protocol was approved by the Institutional Review Board of the 
University of Minnesota. All participants gave informed consent prior to the experiment. 
None of the participants were receiving Botox treatment or undergoing any other 
treatment during the course of the study, and their voice was at the symptomatic stage. 
Table 4. Clinical characteristics of study participants. (F: female)  
Subject 
ID 























192 NA 192 
ABSD 3 F 52 ABD No Mild 9 NA NA 
ABSD 4 F 50 ABD No Severe 120 NA 96 
ABSD 5 F 59 ABD No Very severe 144 NA 48 
 
Apparatus 
We used the developed device as the apparatus for this study (See Figure 9). The 
vibration frequency for VTS was set to100Hz in this study. 
Experimental Procedure and Behavioral Task 
The experiment took place at the Multiple Sensory Perception Laboratory at the 
University of Minnesota. Before asking the participant to wear the collar, the participant's 
width of the thyroid cartilage was measured. Accordingly, the vibrators were moved 
horizontally to be positioned laterally to the thyroid cartilage. Then, the participants sat 
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on a comfortable chair and instructed to wear the device without any help from the 
investigators (see Figure 13). 
We activated the VTS for two sets of 5-minute periods using the continuous VTS 
operational mode of the device. After the second VTS set, participants filled out the 
developed usability questionnaire (see Appendix II) to provide their feedback.  
 
Figure 13. Setup for the wearable device around the neck. 
Results 
The task of wearing the device with no assistance was neutral for 1 (ABSD 4), easy for 1 
(ABSD3), and very easy for 3 (ABSD1, ABSD2, ABSD5) of the participants. Only one 
participant (ABSD4) required assistance to put on the collar. However, wearing the 
device was uncomfortable for 1 (ABSD4), neutral for 1 (ABSD3), comfortable for 1 
(ABSD1), and strongly comfortable for 2 (ABSD2, ABSD5) of the individuals. 
When asked about the restriction of the collar around the neck, two responded tight 
(ABSD3, ABSD5), one neutral (ABSD4), one unrestricted (ABSD 1), and one very 
unrestricted (ABSD2). In addition, except for one (ABSD4), none of the participants 
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indicated that their neck movement was restricted. None of the participants had any 
difficulty swallowing, and the collar fabric was felt neutral or pleasant on their skin. 
During the VTS, the vibration frequency was comfortable for all participants. It had no 
side effects and did not irritate their skin. For two of the participants (ABSD1, ABSD4), it 
was difficult to talk while wearing the device when the VTS was off. However, after VTS 
was on, it became easier for one participant (ABSD 1) to speak. 
The immediate participants’ subjective change in the voice quality after the onset of VTS 
was unnoticeable for 1 (ABSD 4) and neutral for 2 (ABSD 2, ABSD 3) individuals, but it 
was noticeable for 2 of them (ABSD 2, ABSD 5). However, the prolonged perceived 
subjective change in the voice quality was noticeable in 2 (ABSD 1, ABSD 5) and very 
noticeable in 1 (ABSD 2) participant. ABSD 1 reported, “spasms felt noticeably lighter, 
less tight”. ABSD 5 stated, “I felt less hesitancy speaking”. Finally, ABSD 2 noted, “I 
didn't feel the need to breathe and prep before speaking; the sounds just came out 
naturally”. 
Discussion 
The goal of this usability study was to explore the utility and functionality of the wearable 
VTS device. Participants wore the wearable device around their necks and experienced 
VTS on their larynx. The main findings of this qualitative research are as follows: 
First, participants reported being comfortable wearing the device around their necks. It 
did not cause any side effects. However, not all participants were comfortable wearing 
the device in public. They were concerned about the noise that the device generates 
because of the activation of the vibratos. Future generations of the device need to 
provide a proper enclosure that can reduce the noise. 
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Second, the application of laryngeal VTS resulted in a subjective improvement of the 
voice quality in two out of 5 participants. Project 3 of this dissertation systematically 
sought to evaluate quantitative effects of laryngeal VTS provided by this project's 
developed device.  
Conclusion 
This project concerned the design and development of a non-invasive neuromodulation 
wearable device that provides laryngeal VTS. The device provides two operational 
modes, continuous VTS and real-time VTS during speech using newly developed 
speech-detection technology. The speech-detection algorithm allows for individualized 
system calibration providing flexibility in adjusting the device for users with different 
anatomy or disease severity. This study was conducted as part of our effort for 
developing a new treatment for SD. Our device can be an important step in advancing 
laryngeal VTS as a therapeutic intervention for improving the voice symptoms in SD. If 
successful, our laryngeal vibration technology could become a low-cost, wearable, non-
invasive treatment for SD, which can enhance the available therapeutic arsenal by either 
augmenting existing Botox therapy or becoming an alternative intervention option for 
patients who do not tolerate Botox injections. 
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PROJECT 3: Obtaining clinical efficacy data of the 
wearable neuromodulation device in a sample of 
patients with AB SD  
People with the abductor type of SD have even more limited treatment options than 
those with AD SD. Most of the AB SD patients do not respond to Botox injection. This 
project specifically targeted people with AB SD to investigate if and how they respond to 
the laryngeal VTS. It used the third-generation prototype of the device described in 
Project 2. This project explored the following questions: 
• Can VTS provide measurable symptomatic relief for patients with AB SD? 
• Do the results of voice quality markers correlate with the improvements observed 
in AD SD patients that were tested in project 1? 
• What are the changes in the cortical activity associated with VTS in AB SD 
patients? 
• Can we observe the same electrocortical responses from project 1 in people with 
AB SD? 
At the time of the submission of this dissertation, the recruitment of patients was not 
completed. I here present all data currently available. This work is funded by the 
National Association of Spasmodic Dysphonia (PI Konczak).  
Specific aims 
Aim 1: Demonstrate the effects of the on-time application of laryngeal vibration using the 
wearable device. Obtain objective markers of voice quality in people with AB SD 
before, during, and after the application of VTS. 
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Aim 2: Monitor the changes in cortical activation patterns associated with laryngeal VTS 
in people with AB SD. Following the approach from project 1, electrocortical 
response to VTS will be measured and compared to people with AD SD. 
Methods 
Participants 
Four people diagnosed with AB SD (4 female; mean age  std: 51.5  14.7 years) were 
recruited and attended the study (See Table 5 for clinical characteristics of study 
participants). The experimental protocol was approved by the Institutional Review Board 
of the University of Minnesota. All participants gave their informed consent prior to the 
experiment.  
None of the patients were receiving Botox treatment or undergoing any other treatment 
in the course of the study, and their voice was in the symptomatic stage. 
Table 5. Clinical characteristics of study participants. (F: female)  
Subject 
ID 














ABSD1 F 34 ABD No 144 NA 141 
ABSD2 F 70 ABD Severe 192 NA 192 
ABSD3 F 52 ABD No 9 NA NA 





We used the wearable VTS device described in detail in Project 2 as the apparatus for 
this study (See Figure 9). EEG data were recorded with the ActiveTwo data acquisition 
system (Biosemi B.V. Ltd, Amsterdam, Netherlands). The sampling rate was set at 4096 
Hz. Brain potentials were captured via Biosemi's 64-channel EEG cap with an equiradial 
system of electrode placement. Participants were guided throughout the experiment by a 
series of two 300-ms long auditory cues (2000 Hz and 900Hz) generated by RPvdsEx 
software (Tucker-Davis Technologies Ltd., Alachua, USA). The developed wearable 
device was used to control the activation of the vibrators. The time-stamp of auditory 
cues was recorded. 
All speech and voice signals were recorded for later offline analysis. An external 
microphone (electret condenser microphone, Sony ECM-88B) was located close to the 
participant's mouth. The microphone was connected to an audio recorder (MixPre-3 II, 
Sounds Devices, LLC.) which transferred the audio data for recording to Audacity 
software via a USB connector. Thus, we were able to monitor the voice activity and 
device function during the trial. 
Experimental Procedure and Behavioral Task 
The experiment took place in an electrically and acoustically shielded chamber at the 
Multiple Sensory Perception Laboratory at the University of Minnesota. Participants sat 
on a comfortable chair, asked to avoid extra movements and to focus their visual gaze at 
a fixation point on the front wall. Before asking the participant to wear the collar, the 
width of the thyroid cartilage of the participant was measured. Accordingly, the vibrators 
moved horizontally to be positioned laterally to the thyroid cartilage. Using a marker on 
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the collar cover (See Figure 9A), we ensured that the microphone was located on the 
center of the larynx. Subsequently, the vibrators were positioned externally and 
bilaterally on the participant's neck over the laryngeal area (see Figure 13).  
Prior to the experiment, the severity of speech symptoms was evaluated in a voice 
assessment task (Baseline) by (1) reading a series of standard sentences (Woodson, 
2010) devised for the evaluation of voice quality in AB/AD SD (For the list of sentences, 
see Appendix I); and (2) pronouncing vowels /i/ and /ɑ/ five times, each lasting four 
seconds. Participants read the sentences at their own comfortable pace and loudness. 
In addition, participants rated their perceived effort level of vocalization immediately after 
the voice assessment task on an ordinal scale of 0 to 10 (0 being with no effort and 10 
being with maximal effort) (See Appendix III) 
The experimental protocol comprised two blocks:  
1) Laryngeal vibration (VTS Only): the laryngeal vibrators were turned on using 
the continuous mode of the device (See Figure 10) for 5 minutes. 
2) Vowel vocalization accompanied by laryngeal VTS (Vocalization + VTS). 
During this condition, participants received two auditory cues. They were 
instructed to start vocalizing vowel /ɑ/ after hearing the first auditory cue 
(1500Hz, duration: 250ms). The participants were asked to cease the 
vocalization after hearing the second auditory cue (900Hz, duration: 250ms). The 
period between two auditory cues was set to 4.5 seconds.  
For this condition, we have modified the speech detection mode of the device 
and developed a new operational mode for speech detection during the 
experiment (see Figure 14). In this setting, the device will detect the onset of 
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speech within 200ms and then turns on stimulation with a 2000ms delay (i.e., at 
2200ms after voice onset). Subsequently, laryngeal VTS will be applied during 
the second half of the vocalization period for 2 seconds (i.e., from 22000-
42000ms). This procedure was repeated 50 times with 4-second long resting 
intervals in between. 
 
Figure 14. Flow chart for the speech detection algorithm during the experiment. A 200-
millisecond signal interval will be evaluated for speech activity. If the interval is classified as 
voiced, a 2 s delay will be introduced to the system. This will allow the participant to vocalize for 2 
s. After the delay, the device will activate the vibrators for 2 s, resulting in Vocalization + VTS 
condition. If the interval is classified as unvoiced, the next 200-millisecond interval will be 
evaluated. The total number of trials (T=50 in project III) and threshold will be assigned manually 
before starting this operational mode. The device will exit this operation mode after activating the 
VTS for assigned total trials (50). m=4500 milliseconds. 
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Both conditions were applied in two sets, with each set lasting 12 minutes. Between 
sets, at the end of set 2, and 20 and 60 minutes after the cessation of VTS (Retention), 
voice/speech quality was evaluated using the same assessment tasks given at Baseline 
(see Figure 15). 
 
Figure 15. The experimental protocol for project III 
Objective Measures of Speech Quality 
Three acoustic signatures characterize the voice symptoms of people with AB SD 
(Edgar et al., 2001): (1) prolonged word and sentence duration, (2) number of phonatory 
breaks, and (3) delayed voice onset time. People with AB SD experience atypical voicing 
gaps that increase word duration, mistimed onset of voicing, and atypical breaks in 
voicing.  
In our study, participants read two sets of standard sentences (Woodson, 2010) for the 
speech evaluation of people with adductor and abductor SD in their normal 
conversational style (See Appendix I). Assessment of these recorded voice data was 
performed offline. Two voice measures were obtained: (1) the duration of speech, and 
(2) the change in the smoothed cepstral peak prominence (CPPs) of voice (See Project I 
for details on CPP).  
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At first, all speech signals were broken and labeled into three categories: 1) 'voiced 
sentences', 2) 'unvoiced sentences’, and 3) ‘unvoiced words’: which made up the 
unvoiced sentences and were comprised of a number of unvoiced phonemes. (See 
Appendix I for the list of each category). Then, CPPs values and speech duration were 
derived. The Audacity software was used to record the audio signals, and PRAAT 
software was used for the acoustic analysis of the voice data. Acoustic analysis was 
performed by individuals blind to experimental conditions. 
EEG signal processing 
The EEGLab toolbox of MATLAB (The MathWorks, Natick, MA) was used for exploring 
the EEG data (Delorme and Makeig, 2004). The EEG signal processing steps were as 
followed: 
1. The data were high-passed filtered at the cut-off frequency of 0.1Hz to address 
possible baseline drifts, and low-pass filtered at 50 Hz. Both filters used a zero-
phase FIR filter. A zero-phase Slepian window filter was used to remove power 
line noise.  
2. Because we used the speech detection technology, the vocalization + VTS task 
did not start at the same time after the first auditory cue for all the trials. Using 
the recorded audio signal, we manually measured the time to vocalization onset 
after the first cue and vocalization duration. We then corrected the EEG signal 
time log of each trial to accommodate these variabilities. 
3. Segments of EEG recordings from 1000ms before vocalization to 4000ms after 
the onset of vocalization were extracted as data epochs using the corrected time 
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logs. The 1000 ms period prior to the vocalization was used as the baseline 
(resting state) for the cortical activity. 
4. In order to weaken the potential effect of non-cortical sources that might have 
been commonly captured by electrodes, each channel was re-referenced to the 
common average of all electrodes. 
5. EEG data were resampled to 500 Hz to decrease the processing time and cost of 
the next steps. 
6. We subsequently used the 'runica' algorithm to perform independent component 
analysis (ICA) on all data channels. ICA is a method to decompose independent 
sources that are linearly mixed. 
7. An automated multiple artifact rejection algorithm, 'SASICA' (Chaumon et al., 
2015) implemented on the resultant components to identify and remove the 
contaminated ICs. This algorithm recruits spatiotemporal criteria to distinguish 
the artifactual components. This is critically important for the identification and 
removal of muscle artifacts that may have contaminated the EEG data during 
vowel vocalization.  
8. Finally, the remaining ICs were linearly summed up, and the output dataset was 
used for extracting the features. 
Electrocortical measures 
As a primary EEG measure, we obtained the event-related spectral perturbation (ERSP) 
of somatosensory-motor cortical electrodes in response to VTS (For details on ERSP, 
see Project I). Band-specific features were separately extracted for the physiologically 
relevant frequency ranges (i.e., <50Hz): theta (4-8Hz), alpha (8-13Hz), beta (13-30Hz), 
61 
 
and the low gamma (30-49Hz). ERSP was extracted for six sites: CP5, C5, FC5, CP6, 
C6, and FC6 (See Figure 4 and Project I for more details).  
EEG features were extracted from the Vocalization + VTS conditions of both sets (see 
Figure 15) to investigate the immediate cortical response to VTS. For each condition, 
the 4000ms long trials were divided into two segments:  
1) VTS-off (before the onset of laryngeal vibration) – Only Vocalization. 
2) VTS-on (after the onset of laryngeal vibration) – Vocalization and vibration. 
For each participant, the ERSP measure of the average of the 50 recorded epochs was 
derived separately for the VTS-off and VTS-on segments. Because the period for 
vocalization onset is variable for each participant and each trial, in some instances, the 
voice activity period might exceed the 4.5 seconds duration between two auditory cues. 
As such, because the second auditory cure additionally contain cortical auditory evoked 
potentials (Alvarenga et al., 2013) or the EEG signal might be influenced by the reaction 
time of the study participants (Santee and Kohfeld, 1977), the period that exceeds the 
onset of the second auditory cue were excluded from further EEG analysis (i.e. the 4.5 
second interval, might be shorter is some trials). For ERSP computation, the outcome 
value is time-normalized; thus, the difference in time duration for analysis does not affect 
the results. 
In order to quantify the changes in the electrocortical activity of participants in response 
to laryngeal VTS, two variables were calculated: 
1) Absolute ERSP change: measured from the subtraction of computed ERSP in 
VTS-on (Vocalization and vibration) from VTS-off (Vocalization): 
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Absolute ERSP change = ERSPVTS-on – ERSPVTS-off   (2) 
The unit of absolute ERSP change is in dB. The negative value of the absolute 
ERSP change indicates an event related desynchronization (ERD) in cortical 
electrodes induced by VTS. Conversely, a positive value for Absolute ERSP is 
defined as event related synchronization (ERS) as a result of VTS application. 
2) Relative ERSP change: measured from dividing absolute ERSP change to the 






   (3) 
Relative ERSP change is unit-less and indicates the magnitude of ERD or ERS 
compared to the ERSP in VTS-off. 
Results 
Participants underwent two sets of vowel vocalization. This study only investigated AB 
SD participants. Vocalizing the vowel /ɑ/ requires an extensive effort for individuals with 
AB SD. During the data collection procedure, we observed that participants experienced 
fatigue at the end of the second vowel vocalization set and their voice quality declined 
(See Figure 24 and Figure 25 in Appendix IV). Because fatigue might have confounded 
the auditory and electrocortical data, we here report only data of set 1, but included the 




Changes in markers of speech quality 
We recorded the voice of 4 AB SD participants as they read a list of sentences devised 
for the speech evaluation of SD (Woodson, 2010) at five different time stamps along with 
the experimental protocol (see Figure 15):  
1) Pretest (Baseline): Prior to VTS; 
2) Post-test 1: After 8.8 minutes of VTS; 
3) Post-set 2: after 17.6 minutes of VTS; 
4) Retention 1: 20 minutes past the cessation of VTS. 
5) Retention 2: 60 minutes past the cessation of VTS. 
Subsequently, we derived the duration and CPPs for each of the three following 
segments, Unvoiced and voiced sentences and unvoiced words (See Appendix I), as 
measures of speech quality from the acoustic signal. 
The clinical and self-perceived markers of speech for the pre-test (baseline) show that 
participants experienced different levels of voice symptom severity (See Table 6). 
Table 6. Clinical and self-perceived markers of speech and voice symptom severity for study 
participants (UVS: unvoiced sentences, VS: voiced sentences, UVW: unvoiced words). 
Subject ID 
Self-Rated Effort Scale Duration (s) 
UVS VS Vowel /e/ Vowel /a/ UVS VS UVW 
ABSD1 5 4 1 3 42.42 23.78 34.39 
ABSD2 7 7 10 9 42.5 26.25 33.4 
ABSD3 3 2 2 3 39.03 25.77 29.28 
ABSD4 8 5 4 3 NA NA NA 
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The speech analysis was completed for 3 participants. Two of the three participants 
(ABSD1 and ABSD3) responded to VTS and showed a reduction in the duration of all 
three voice segments, unvoiced and voiced sentences, and unvoiced words at Post-set 
1 as compared to Pretest. ABSD1 showed the greatest change in the duration variables 
and also a rise of CPPs (> +1dB) for unvoiced and voiced sentences (See Figure 16A). 
The participant ABSD2, who was diagnosed with AB SD and severe voice tremor, did 
not show any improvements (See Figure 16B). Improvements in all six speech quality 
measures for the ABSD1 were preserved at both 20 and 60-minute retention stages (see 
Figure 17A and Figure 18A). For ABSD3, the effect of VTS declined after 20 minutes 





Figure 16. Change in the duration and CPPS at Post-set1 in comparison to Baseline (Pretest). An improvement in voice quality will be achieved 
by a decrease in duration and increase in CPPs. The numbers on the graph represent the percentage of change in comparison to baseline 
(100%). A) ABSD1 showed an improvement in both duration and CPPs changes. B) ABSD2 did not experience any improvement. C) ABSD3 




Figure 17. Change in the duration and CPPS at Retention 1 (20 minutes after VTS) in comparison to Baseline (Pretest). The numbers on the 
graph represent the percentage of change in comparison to baseline (100%). A) ABSD1 showed an improvement in both duration and CPPs 
changes. B) ABSD2 did not experience any improvements, except a decrease in voice sentences duration. C) ABSD3 showed only minor 




Figure 18. Change in the duration and CPPS at Retention 2 (60 minutes after VTS) in comparison to Baseline (Pretest). The numbers on the 
graph represent the percentage of change in comparison to baseline (100%). A) ABSD1, the improvements in both duration and CPPs changes 
were still present. B) ABSD2 experienced minor improvements in the duration but did not experience any improvements in CPPs. C) ABSD3, 
returned to the baseline status. 
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UVS VS UVW UVS VS UVW UVS VS UVW UVS VS UVW 
ABSD1 1 2.2 0.9 0.9 1.8 0.8 1.6 2.7 1.4 1.4 1.8 1.2 
ABSD2 -1.1 -1.3 -1 0 -0.3 0.4 -0.7 -1.1 -0.6 0 -1.3 0 
ABSD3 0.7 0.8 0.7 1.6 1.2 2.1 0.5 0.1 0.8 0.4 -0.1 0.7 
ABSD4 NA NA NA NA NA NA NA NA NA NA NA NA 
Table 8. VTS induced change in the duration (duration) of unvoiced sentences (UVS), voiced sentences (VS), unvoiced words (UVW) relative to 










UVS VS UVW UVS VS UVW UVS VS UVW UVS VS UVW 
ABSD1 -10.8 -3.9 -8.1 -8.3 -1.8 -5.8 -14.8 -4.9 -11.3 -13.6 -3.5 -9.7 
ABSD2 0.2 -3.6 -0.7 15.5 -0.3 3 3 -3.1 -0.2 -2.3 -2 -3 
ABSD3 -2.9 -1.8 -2.1 -4.1 -2 -3.2 -3.5 -0.9 -2.5 0 0.7 0.6 
ABSD4 NA NA NA NA NA NA NA NA NA NA NA NA 
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Change in the cortical oscillatory behavior in response to laryngeal VTS 
The effect of the first 8.8 minutes of VTS (set 1 in Figure 15) on cortical oscillatory 
activity over the premotor, motor, and somatosensory cortex showed variable 
electrocortical responses in the four participants. For cortical theta-band oscillations (4-8 
Hz), ABSD1 and ABSD2 showed event related synchronization (ERS) for both right and 
left cortical electrodes (FC6, C6, CP6, FC5, C5, and CP5). However, ABSD 3 observed 
event related desynchronization (ERD) in right cortical electrodes. Conversely, ABSD4 
showed ERD for all the left hemisphere cortical electrodes (See Figure 19). The result of 
ABSD4 is aligned with what was recorded in project 1. 
The first set of VTS in ABSD1 induced ERD of the cortical alpha frequency band (8-
13Hz) in left somatosensory and motor cortical electrodes (CP5 and C5). The result in 
ABSD3 was in contrast, showing ERS in CPS and C5. ABSD2 and ABSD4 showed ERS 
in all the electrodes, except CP5 in ABSD4, for the alpha oscillation band (See Figure 
20). The VTS induced activity in cortical frequency band of Beta (13-30 Hz) in ABSD2, 
ABSD3, and ABSD4 resulted in ERS in all cortical electrodes, except FC6 in ABSD2. 
However, ABSD1 observed ERS only in C6, CP6, and FC5 (See Figure 21). Finally, the 
cortical activity in the lower gamma frequency band (30-50 Hz) showed ERD in all 
cortical electrodes for ABSD2 and ABSD3 (except FC6 in ABSD3). ABSD1 observed 
ERS only in C5, CP5, and CP6. However, ABSD4 showed ERS in all the cortical 




Figure 19. Change in ERSP over the somatosensory, motor, and premotor cortical areas for thet- 
band (4 to 8 Hz) during Vocalization+VTS compared to Vocalization in Set 1 (See Figure 15). 
Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 did not observe any 
desynchronization. B) ABSD2 did not experience any desynchronization. C) ABSD3 experienced 
desynchronization in right cortical electrodes (FC6, C6, and CP6) and left motor electrode (C5). 
D) ABSD4 showed suppression of all left cortical electrodes. The result that was observed in 





Figure 20. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
alpha-band (8 to 13 Hz) during Vocalization+VTS compared to Vocalization in Set 1 (See Figure 
15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 observed 
desynchronization only in C5, CP5, and FC6. B) ABSD2 experienced synchronization in all the 
electrodes. C) ABSD3 experienced synchronization in two of the left cortical electrodes (CP5 and 
C5). D) ABSD4 had synchronization in all the electrodes except CP5. Unit for the absolute 




Figure 21. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
beta-band (13 to 30 Hz) during Vocalization+VTS compared to Vocalization in Set 1 (See Figure 
15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 observed 
desynchronization only in C5, CP5, and FC6. B) ABSD2 experienced synchronization in all the 
electrodes, except FC6. C) ABSD3 experienced synchronization in all the cortical electrodes. D) 




Figure 22. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
lower gamma band (30 to 50 Hz) during Vocalization+VTS compared to Vocalization in Set 1 
(See Figure 15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 
observed synchronization only in C5, CP5, and CP6. B) ABSD2 experienced desynchronization 
in all the electrodes. C) ABSD3 experienced desynchronization in all the cortical electrodes 





Table 9. ERSP values over the somatosensory, motor, and premotor cortical areas for theta band (4 to 8 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 1 -2.01 -0.28 -2.12 -0.37 -1.77 -0.61 -1.31 -1.02 -1.26 -0.27 -1.40 -0.07 
ABSD2 1 -1.66 -0.69 -2.20 -0.84 -3.40 -1.00 -0.65 0.59 -0.49 0.75 -0.77 0.78 
ABSD3 1 -0.85 -0.64 -1.07 -0.71 -1.26 -1.43 -0.88 -1.60 -0.62 -1.25 -0.74 -1.00 
ABSD4 1 -0.08 -0.54 0.99 0.05 1.04 0.06 -0.57 -0.30 -1.53 -0.85 -2.28 -1.92 
 
Table 10. ERSP values over the somatosensory, motor, and premotor cortical areas for alpha band (8 to 13 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 1 -0.67 -0.13 -0.25 -0.44 -0.18 -0.49 -1.03 -1.39 -1.51 -1.26 -0.83 -0.36 
ABSD2 1 -3.12 -0.88 -4.65 -2.03 -6.19 -2.58 -1.86 -0.28 -0.85 0.63 -1.16 0.22 
ABSD3 1 -1.29 -1.36 -1.76 -1.25 -1.35 -1.11 -1.56 -1.90 -1.52 -1.84 -1.13 -1.41 





Table 11. ERSP values over the somatosensory, motor, and premotor cortical areas for beta band (13 to 30 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 1 0.75 1.12 2.23 2.14 2.88 2.75 1.04 0.79 0.18 0.51 0.39 0.88 
ABSD2 1 -2.67 -2.63 -1.29 -0.66 -0.78 -0.21 -0.39 -0.44 -0.31 -0.19 0.04 0.16 
ABSD3 1 -0.08 0.35 -0.43 0.33 -0.51 0.19 -0.69 -0.11 -0.49 -0.17 -0.30 0.07 
ABSD4 1 -0.16 0.49 0.08 0.46 0.08 0.32 0.25 0.95 -0.03 0.59 -0.25 0.02 
 
Table 12. ERSP values over the somatosensory, motor, and premotor cortical areas for lower gamma band (30 to 50 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 1 1.15 0.89 3.17 3.41 3.65 3.99 1.53 1.14 0.70 0.40 1.25 1.40 
ABSD2 1 -4.42 -5.17 -1.92 -2.71 -0.77 -1.49 -1.89 -2.04 -0.58 -0.85 1.14 0.76 
ABSD3 1 -0.18 -0.80 -0.80 -1.22 -0.45 -0.47 0.59 0.70 -0.09 -0.98 -0.34 -0.78 





This is the first study (albeit a “pilot: study) that investigated the effects of laryngeal 
vibration on voice symptoms in people with AB SD. At the time of submission of this 
dissertation, the recruitment was not completed, and only data of four participants is 
reported. Because of this limited data set, it was not opportune to perform any inferential 
statistics on possible treatment effects. Thus, the main focus reports the individual data 
of the four participants with AB SD and contrast their voice and EEG data to the results 
of project 1, which applied the same VTS to people with AD SD. One participant, SD05, 
from project 1 was diagnosed with AB SD. He showed improvement in voice quality after 
VTS (See Figure 5). We have included this participant in this project’s discussion. The 
main findings of this research are as follows:  
First, a one-time application of VTS on people with AB SD in three out of four 
participants (ABSD1, ABSD3, and SD05) showed an improvement in one of the markers 
of speech production. The effect persisted in two of them (ABSD1 and SD05) after 20 
minutes and one, ABSD1, after 60 minutes after cessation of VTS. The results imply that 
VTS has a potential positive effect in at least a subsection of patients with AB SD. This 
initial data set confirmed that VTS can potentially have a beneficial effect on the voice 
symptoms in people with abductor-type SD. This finding extends on the previous 
research of project 1, showing that laryngeal VTS can ameliorate the voice symptoms in 
AD SD. As with the AD SD group of project 1, there are subgroups of “responders” and 
“non-responders” to the laryngeal VTS. However, at this point, more data on AB SD are 
required to determine a more firm rate of effectiveness in this group. 
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Second, we expected that the application of laryngeal VTS in AB SD to induce similar 
electrocortical responses as seen project 1. However, we did not observe the same 
consistent results. For instance, although ABSD1 observed improvement in voice quality 
markers but did not show an immediate significant suppression of theta band 
synchronization over the left somatosensory-motor cortex. However, we observed alpha-
band synchronization in ABSD1 (See Figure 20). The same response was also 
observed in SD05, who participated in project 1 (See Figure 23 in Appendix IV). 
Furthermore, the immediate significant rise of gamma-band was observed over the right 
somatosensory-motor cortical region of SD05 but was only present in motor cortical 
region of ABSD1. The data suggest that we might notice ERD/ERS in other oscillatory 
cortical bands or regions in AB SD that were not significant in project 1. In addition, there 
might be some similarities within or across two types of SD. Unfortunately, we do have 
sufficient data at this stage to substantiate the results and provide a cortical activity 
pattern in AB SD. 
Limitations of the study 
The repetitive vocalization of vowel /a/ required substantial efforts from the AB SD 
participants. This resulted in exhaustion at the end of the second set of VTS (see Figure 
15) and a decline in the voice quality. However, the voice quality improved after the 20-
minute break for retention (see Figure 15). We did not face this challenge in project 1, 
as most of the participants were diagnosed with AD SD. Modification in the experimental 




Another major challenge was incorporating a speech detection algorithm for providing 
periodic laryngeal VTS during vowel vocalization and EEG data collection. In the current 
study, we provided two auditory cues to control the timing of the vocalization. However, 
because people with AB SD experience delayed in the time for the onset of voice (Edgar 
et al., 2001), the participants did not start vocalization immediately after the first auditory 
cue. In some instances, the delay was more than one second. This delay in onset might 
result in an overlap between the second auditory cue and the Vocalization and VTS task. 
In this study, to avoid the interference of cortical activity of the second auditory cue and 
VTS, we only analyzed the period up to the second auditory cue. Future studies need to 
modify the experiment protocol and remove the second auditory cue. Because the 
vibrators will automatically turn off after two seconds (see Figure 14), the participant can 
end vocalization after VTS is ceased in each trial. 
Like already discussed in project 1, the lack of an established clinical rating scale to 
assess disease severity limits the interpretation of the voice as well as the EEG-based 
data. From a clinical and therapeutic point of view, it would be highly desirable to be able 
to correlate improvements in voice quality due to laryngeal VTS and the associated EEG 
responses to markers of disease severity in order to understand what patient profile 
would predict the effectiveness of laryngeal VTS.  
Conclusions 
This study provided initial foray into the effectiveness of laryngeal VTS on voice quality 
and cortical activity of people AB SD. The results suggested that, in principle, laryngeal 
VTS can induce improvements in voice quality in people with AB SD. This preliminary 
finding aligns with the results observed in project 1 that showed that laryngeal VTS 
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alleviated voice symptoms in approximately 70% of people with AD SD. However, we 
require a larger sample to have a confident response rate to the laryngeal VTS in AB 
SD. The current analysis of electrocortical responses to VTS in people with AB SD did 
not closely mimic the event -elated cortical activity patterns seen in AD SD. More data 
are needed to delineate consistent patterns of cortical responses induced by laryngeal 
VTS in AB SD, but the project shows that a promising outcome may result.  
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This dissertation describes the evolution of an idea for an intervention to an advanced 
prototype of a medical device that may deliver such intervention. I have completed the 
necessary stages of both the development and commercialization of a wearable medical 
device as a non-invasive neuromodulation treatment. The following are 
recommendations for future work that are required for translating the current prototype 
into a commercially available medical device:  
1. A smart-phone based application needs to be developed to control the device, 
removing the burden of the presence of an expert to operate the device. 
2. The developed device needs to be tested on a large patient population both for 
short and long durations. The user’s usability responses will guide the 
development of future generations of the device. 
3. SD is a rare disorder, and patient recruitment remains the main challenge for 
conducting research on SD. A multi-center longitudinal clinical trial with a large 
patient sample will provide insights into the long term effects of laryngeal VTS on 
voice quality and electrocortical activity in SD. This developed wearable device 
has the potential to be a suitable approach to provide VTS. It increases 
accessibility and eliminates the purchasing equipment that are necessary for 
controlling the stimulation. In addition, the device provides the opportunity to set 
up a portable testing site. 
4. Another approach for overcoming the recruitment challenge using the developed 
device is to conduct remote testing. The device can be shipped to the patients, 
and an investigator will be able to conduct remote control of the device to 
conduct the study. 
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5. The device can be sent to the patient for in-home testing for a limited period 
(e.g., one month). The patient can use the technology during activities of daily 
living. Such a study can provide a clearer understanding of the effectiveness of 
laryngeal VTS beyond the laboratory environment. 
6. Further studies are required to investigate the effect of VTS on other neurological 
disorders such as cervical dystonia, focal hand dystonia, and chronic cough. 
7. Finally, with some modifications, the developed wearable device can be adapted 
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Voiced sentences  
1) Tom wants to be in the army. 
2) We eat eels every day. 
3) He was angry about it all year 
4) I hurt my arm on the iron bar. 
5) Are the olives large? 
6) John argued ardently about honesty. 
7) We mow our lawn all year. 
8) Jane got an apple for Ollie. 
9) A dog dug a new bone 
10) Everyone wants to be in the army. 
Unvoiced sentences 
1) He is hiding behind the house. 
2) Patty helped Kathy carve the turkey. 
3) Harry is happy because he has a new horse. 
4) During babyhood he had only half a head of hair 
5) Who says a mahogany highboy isn't heavy? 
6) Boys were singing songs outside of our house. 
7) The puppy bit the tape 
8) See, there's a horse across the street. 
9) Sally fell asleep in the soft chair. 
10) The policy was suggested in an essay on peace. 
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Unvoiced words: The words are underlined. (47 words) 
1) He is   hiding   behind  the  house. 
W01  W02  W03   W04 
2) Patty   helped  Kathy   carve   the  turkey. 
W05  W06  W07  W08   W09 
3) Harry  is  happy   because  he  has  a new  horse. 
W10  W11  W12  W13 W14  W15 
4) During baby hood, he  had  only  half  a  head  of  hair. 
  W16 W17 W18  W19  W20  W21 
5) Who   says  a  mahogany  high boy isn’t  heavy? 
W22  W23  W24  W25   W26 
6) Boys were  singing  songs   outside  of our  house. 
  W27  W28  W29   W30 
7) The  puppy   bit  the  tape. 
 W31  W32  W33 
8) See,   there’s  a  horse   across  the  street. 
W34  W35   W36  W37   W38 
9) Sally   fell  asleep   in the   soft   chair. 
W39  W40 W41    W42  W43 
10) The  policy  was suggested  in an   essay   on  peace. 




1. What is the type of your voice disorder? 
• Adductor spasmodic dysphonia (ADD SD) 
• Abductor spasmodic dysphonia (ABD SD) 
• Mixed (both ABD and ADD SD) 
• Muscle tension dysphonia 
 
2. Do you have voice tremor? Yes/No. 
3. How often do you find yourself repeating your sentences because your 
peers have difficulty understanding you? 
Very frequently Frequently Infrequently Very infrequently Never 
4. What do you think is the severity of your voice disorder? 
Very Mild Mild Severe Very severe 
Extremely 
severe 
5. Are you taking Botulium toxin injection? Yes/No 
a. If yes, what is the frequency of your Botox injection? 
 
6. Are you undergoing any other treatment besides Botox injection? Yes/No 
a. If yes, please elaborate? 
 
7. How difficult was it to put on the device by yourself? 
Very difficult Difficult Neutral Easy Very easy 
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8. Did you require assistance to put on the collar? Yes/No.  
a. If yes, how could we make it easier for you? 
 
9. How comfortable was it for you to wear the collar? 
Strongly 
uncomfortable 




10.  Assuming that you could choose the fabric color and/or design, would you 
feel comfortable wearing this collar in public? 
Strongly 
uncomfortable 
Uncomfortable Neutral Comfortable 
Strongly 
comfortable 
a. If you chose below neutral, what is the reason? 
 
b. In what way could we redesign the device to increase your comfort level? 
 
11. How restricted was the collar around your neck? 
Very tight Tight Neutral Unrestricted 
Very 
unrestricted 
12. How restricted was your neck movement while you wore the collar? 
Very restricted Restricted Neutral Unrestricted 
Very 
unrestricted 
13. How difficult was it to swallow while you had the collar around your neck 
and the vibrators were on? 
Very difficult Difficult Neutral Easy Very easy 
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14. How did the fabric of the collar feel on your skin?  
Very irritating Irritating Neutral Pleasant Very pleasant 
15. When in operation (vibrators are “on”), did the device irritate your skin? 
Yes/No 
16. Did you feel the level of vibrator level is uncomfortable? Yes/No 
a. If you chose yes, did you have any side effects (e.g., soreness, continuous 
tingling after vibration had ended, skin irritation, etc.)? Yes/No 
 
b. If you had any side effects, please describe them briefly? 
 
17. How difficult was it to talk while wearing the collar, and it was NOT 
vibrating? 
Very difficult Difficult Neutral Easy Very easy 
18. How difficult was it to talk while wearing the collar, and it was vibrating? 
Very difficult Difficult Neutral Easy Very easy 
19. How do you feel your voice changed while wearing the collar and the 
vibrators were OFF? 
Very 
unnoticeable 
Unnoticeable Neutral Noticeable 
Very 
unnoticeable 
20. How do you feel your voice or voice quality changed while wearing the 
collar and immediately after the vibrators were ON? 
Very 
unnoticeable 









Unnoticeable Neutral Noticeable 
Very 
unnoticeable 
22. If you responded above “Neutral” to the previous question, please explain 
the noticeable changes. 
 
 
23. What was the voice production effort while wearing the collar when 
compared to not wearing it? 
Very 
demanding 








10 Maximum vocal effort 
9 Very very severe vocal effort (almost maximum) 
8   
7 Very severe vocal effort 
6   
5 Severe vocal effort 
4 Somewhat severe vocal effort 
3 Moderate vocal effort 
2 Slight vocal effort 
1 Very slight vocal effort 
0.5 Very very slight vocal effort (just noticeable)  






Figure 23. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
SD05 in project 1 during Vocalization+VTS compared to Vocalization in Set 1 (See Figure 3). 
SD05 was diagnosed with AB SD (See Table 1). Arrows reflect the data for all six electrodes 
(See Figure 4). A) Theta band (4 to 8 Hz). All electrodes showed synchronization except CP5. B) 
Alpha band (8 to 13 Hz). SD05 observed desynchronization in C6, CP6, and CP5. The change in 
GC5 and FC6 was minor. C) Beta band (13 to 30 Hz). All cortical electrodes resulted in 
desynchronization except CP5. D) Lower gamma band (30 to 50 Hz). All the electrodes, except 
FC5, resulted in synchronization in the lower gamma band. Unit for the absolute change is in dB 






Figure 24. The duration of the reading of the voice tasks during the experiment (see Figure 15). 
The data from Post-VTS 2 shows that the voice quality decreases. The participants were fatigued 





Figure 25. The change in CPPs value compared to the baseline for voice assessment sections 
tasks of the experiment protocol (See Figure 15). The data from Post-VTS 2 shows that the voice 
quality decreases. The participants were fatigued from the set 2 vocalization.  A) Unvoiced 





Figure 26. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
theta band (4 to 8 Hz) during Vocalization+VTS compared to Vocalization in Set 2 (See Figure 
15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 did not observe any 
desynchronization. B) ABSD2 did not experience any desynchronization. C) ABSD3 experienced 
desynchronization in right cortical electrodes (FC6, C6, and CP6) and left motor (C5) and 
premotor (FC5) cortical electrodes. D) ABSD4 showed suppression of left somatosensory (CP5) 




Figure 27. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
Alpha band (8 to 13 Hz) during Vocalization+VTS compared to Vocalization in Set 2 (See Figure 
15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 observed 
synchronization in all electrodes. B) ABSD2 experienced synchronization in all electrodes except 
FC6. C) ABSD3 experienced desynchronization in all electrodes except CP5. D) ABSD4 had 




Figure 28. Change in ERSP over the somatosensory, motor, and premotor cortical areas for Beta 
band (13 to 30 Hz) during Vocalization+VTS compared to Vocalization in Set 2 (See Figure 15). 
Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 observed 
desynchronization only in C6 and FC6. B) ABSD2 experienced synchronization in all the 
electrodes. C) ABSD3 experienced desynchronization in all the cortical electrodes except C5 and 




Figure 29. Change in ERSP over the somatosensory, motor, and premotor cortical areas for 
lower gamma band (30 to 50 Hz) during Vocalization+VTS compared to Vocalization in Set 2 
(See Figure 15). Arrows reflect the data for all six electrodes (See Figure 4). A) ABSD1 
observed synchronization only in C5 and FC5. B) ABSD2 experienced synchronization in all the 
electrodes. C) ABSD3 experienced synchronization in all the cortical electrodes except FC6. D) 
ABSD4 had synchronization in only FC6, C6, and CP6. Unit for the absolute change is in dB. 
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Table 13. ERSP values over the somatosensory, motor, and premotor cortical areas for theta band (4 to 8 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 2 -2.28 -0.17 -2.21 -0.41 -0.97 0.95 -1.11 -0.18 -1.04 0.31 -1.42 0.42 
ABSD2 2 -0.64 -0.67 -1.66 -1.43 -3.56 -2.45 -1.46 -0.93 -0.51 0.08 0.07 0.89 
ABSD3 2 1.31 0.55 0.58 0.39 0.07 0.53 0.85 -0.53 0.60 -1.37 0.64 -0.72 
ABSD4 2 0.62 1.08 1.11 1.28 1.02 0.76 -0.13 -0.12 0.23 0.13 0.18 -0.13 
 
Table 14. ERSP values over the somatosensory, motor, and premotor cortical areas for alpha band (8 to 13 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 2 -0.57 -0.17 -0.84 -0.55 0.01 0.57 -0.52 0.16 -0.37 0.51 -0.27 0.18 
ABSD2 2 -0.31 0.55 -1.69 -0.81 -3.69 -2.88 -1.17 -1.93 -0.15 0.58 0.36 1.71 
ABSD3 2 0.30 -0.74 -0.18 -0.40 -0.08 -0.04 0.55 -1.05 0.15 -1.76 -0.58 -1.94 




Table 15. ERSP values over the somatosensory, motor, and premotor cortical areas for Beta band (13 to 30 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 2 0.05 0.22 0.27 0.28 0.79 0.85 1.35 0.60 0.72 0.62 0.07 0.30 
ABSD2 2 -0.23 0.26 -0.52 0.37 -0.73 0.45 0.26 0.45 -0.87 -0.08 -0.36 0.38 
ABSD3 2 -0.03 -0.16 -0.33 -0.12 -0.45 -0.32 0.36 -0.45 0.10 -0.86 -0.52 -1.44 
ABSD4 2 -0.08 -0.47 0.35 0.17 0.40 0.24 -0.11 -0.37 -0.04 -0.12 0.08 -0.17 
 
Table 16. ERSP values over the somatosensory, motor, and premotor cortical areas for lower gamma band (30 to 50 Hz) for Vocalization and 




FC5 C5 CP5 FC6 C6 CP6 
Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS Voc Voc+VTS 
ABSD1 2 0.11 0.61 1.01 1.35 1.66 1.46 3.16 2.41 1.85 1.56 1.22 1.02 
ABSD2 2 -1.19 -1.20 -0.06 0.37 0.64 1.31 -2.28 -2.27 -2.17 -2.01 -1.37 -0.75 
ABSD3 2 -1.15 -1.95 -1.13 -1.17 0.07 -0.04 -0.15 -0.44 -0.99 -1.40 -0.98 -1.38 
ABSD4 2 0.02 -0.40 0.84 0.61 0.06 -0.05 -0.30 -0.26 -0.13 0.26 -0.03 1.16 
 
